What are INDmoney investors doing with Jubilant Pharmova shares?
Based on platform-user behaviour - not analyst opinion or company fundamentals.
Search interest on INDmoney
+48%
Searches for Jubilant Pharmova on INDmoney have increased by 48% over the last 30 days.
Investment activity on INDmoney
+198.81%
Investment activity in Jubilant Pharmova among INDmoney users has increased by 198.81% over the last 30 days.
Average holding period of indmoney investors
44 days
INDmoney investors hold Jubilant Pharmova shares for an average of 44 days.
Key Events for Jubilant Pharmova
Jubilant Pharmova Stock Performance
as on September 16, 2026 at 6:27 pm IST
Day's Low
Day's High
₹977.50₹1,010.00
2.85%
Downside
0.38%
Upside

52 Week's Low
52 Week's High
₹786.05₹1,184.80
21.88%
Downside
17.75%
Upside

Jubilant Pharmova share price movements today
- Previous Close
- ₹1,011.95
- Open
- ₹1,006.25
- Volume
- 93.09K
- Upper Circuit
- ₹1,214.30
- Lower Circuit
- ₹809.60
- Day's Low - High
- ₹977.50 - ₹1,010.00
- 52 Week Low - High
- ₹786.05 - ₹1,184.80
Jubilant Pharmova Historical Returns
- 1 Month Return
- + 16.73 %
- 3 Month Return
- + 3.26 %
- 1 Year Return
- -9.68 %
- 3 Year Return
- + 128.48 %
- 5 Year Return
- + 61.51 %
Jubilant Pharmova Fundamentals
as on September 16, 2026 at 12:57 pm IST
Market Cap
₹16,120.36 Cr
Return on Equity (ROE)
3.06
PE Ratio (TTM)
46.12
Return on capital employed (ROCE)
1.79
Industry PE ratio
51.81
Beta (LTM)
0.62
P/B Ratio
5.61
Dividend Yield
0.61
PEG Ratio
-6.77
Quarterly Earnings Growth YOY
-44.98
EPS (TTM)
25.16
Book Value
448.91
Jubilant Pharmova Stock Valuation
as on September 16, 2026 at 12:57 pm IST
Jubilant Pharmova in the last 5 years
Lowest (-195.50x)
December 29, 2023
Today (46.12x)
September 11, 2026
Industry (51.81x)
September 11, 2026
Highest (257.22x)
February 16, 2024
Today’s Price to Earnings Ratio: 46.12x
Jubilant Pharmova Technical Analysis
Track how Jubilant Pharmova technical analysis has moved over time to understand its trends.
Technicals Summary
Bearish
Neutral
Bullish
Moving Averages
Bearish
Neutral
Bullish
Oscillators
Bearish
Neutral
Bullish
Overall
Oscillators
Name | Value | Action |
|---|---|---|
MACD level (12,26) | 0.53 | |
CCI (20) | -583.37 | Bullish |
RSI (14) | 55.07 | Neutral |
Momentum (10) | -0.25 | |
ADI (14) | 37.71 | |
Ultimate Oscillator (7,14,28) | 80.88 | Bullish |
Moving Averages
Name | Value | Action |
|---|---|---|
SMA (20) | 1005.47 | |
EMA (20) | 1004.95 | Bullish |
VWMA (20) | 1005.38 | |
SMA (50) | 1003.79 | Bullish |
EMA (50) | 1003.95 | Bullish |
SMA (200) | 997.59 | Bullish |
EMA (200) | 1001.39 | Bullish |
KAMA (200) | 1002.35 | Bullish |
DEMA (200) | 1000.58 | Bullish |
Jubilant Pharmova Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Jubilant Pharmova with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 16,120.36 | 12.3% | 0.73 | 397 | 8,279 | |
| HOLD | 16,206.82 | -4.25% | 0.62 | 150 | 2,268 | |
| NA | 6,101.01 | -7.47% | 0.66 | 1,553 | 1,879 | |
| BUY | 14,764.74 | 44.58% | 0.68 | 281 | 1,703 | |
| BUY | 17,278.08 | 15.65% | 0.57 | 320 | 1,875 |
Market expectation of Jubilant Pharmova Stock
Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data
75.00%
Buy
0.00%
Hold
25.00%
Sell
Jubilant Pharmova Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Jubilant Pharmova Ltd Annual Profit & Loss
Figures in Rupees Crores
Jubilant Pharmova Ltd Cash Flow
Figures in Rupees Crores
Mutual Funds Buying / Exiting Jubilant Pharmova
Holdings as of 15 Sep 2026 · based on the latest SEBI-mandated portfolio disclosures
Mutual Funds Buying Jubilant Pharmova
Sorted by largest increase in holding, month-over-month.
Fund Name | Value of Holding | Increase (MoM) | Holding % |
|---|---|---|---|
Bandhan Small Cap Fund Direct Growth | ₹400.02 Cr | ₹20.99 Cr (+5.54%) | 1.2% |
Bandhan Focused Fund - Direct Plan - Growth | ₹120.29 Cr | ₹5.86 Cr (+5.12%) | 5.36% |
Mutual Funds Exiting Jubilant Pharmova
Sorted by largest decrease in holding, month-over-month.
No exiting activity data available right now
Jubilant Pharmova Corporate Actions
View detailed summary of the earnings and dividend history of Jubilant Pharmova.
Jubilant Pharmova Ltd Earnings Results
Jubilant Pharmova Ltd’s net profit fell -45.09% since last year same period to ₹56.50Cr in the Q1 2026-2027. On a quarterly growth basis, Jubilant Pharmova Ltd has generated -52.68% fall in its net profits since last 3-months.
Read More about Earnings ResultsJubilant Pharmova Ltd Dividends May,2026
In the quarter ending March 2026, Jubilant Pharmova Ltd has declared dividend of ₹5.00 per share on 22 May 2026 - translating a dividend yield of 0.49%.
Read More about Dividends
Indices Featuring Jubilant Pharmova Stock
Check stock indices that include Jubilant Pharmova.
Insights on Jubilant Pharmova Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up

Mutual Funds have increased holdings from 8.03% to 8.99% in Jun 2026 quarter
POSITIVE IMPACTPrice Rise

In the last 1 month, JUBLPHARMA stock has moved up by 16.7%
NO EFFECTAgainst Peers

In the last 1 year, Divis Laboratories Ltd has given 50.8% return, outperforming this stock by 60.5%
NO EFFECTAgainst Peers

In the last 3 years, Torrent Pharmaceuticals Ltd has given 157.4% return, outperforming this stock by 28.9%
NO EFFECTPromoter Holding Unchanged

Promoters holdings remained unchanged at 47.68% of holdings in Jun 2026 quarter
NEGATIVE IMPACTProfit Down

Netprofit is down for the last 2 quarters, 119.4 Cr → 56.5 Cr (in ₹), with an average decrease of 52.7% per quarter
NEGATIVE IMPACTRetail Holding Down

Retail Investor have decreased holdings from 24.24% to 23.50% in Jun 2026 quarter
NEGATIVE IMPACTFII Holding Down

Foreign Institutions have decreased holdings from 15.90% to 15.87% in Jun 2026 quarter
NEGATIVE IMPACTRevenue Fall

Revenue is down for the last 2 quarters, 2.31K Cr → 2.24K Cr (in ₹), with an average decrease of 2.8% per quarter
About Jubilant Pharmova Ltd
Revenue: ₹2,221.10Cr as on June 2026 (Q1 FY27)
Net Profit: ₹56.40Cr as on June 2026 (Q1 FY27)
Listing date: 09 Nov, 1994
Chairperson Name: Shyam S Bhartia
| Organisation | Jubilant Pharmova Ltd |
| Headquarters | Noida |
| Industry | Pharmaceuticals |
| CEO | Shyam S Bhartia |
| E-voting on shares | Click here to vote |
FAQs
What is Jubilant Pharmova share price today?
Jubilant Pharmova share price today stands at ₹1006.2 as on . Jubilant Pharmova share today touched a day high of ₹1010 and a low of ₹977.5.
What is the 52 week high and 52 week low range for Jubilant Pharmova share?
Jubilant Pharmova touched a 52 week high of ₹1184.8 and a 52 week low of ₹786.05. Jubilant Pharmova share price today i.e. is trending at ₹1006.2, which is -15.07% down from its 52 week high and 28.01% up from its 52 week low.
What is Jubilant Pharmova's market capitalisation today?
Jubilant Pharmova market capitalisation is ₹16,120.36 Cr as on .
How to buy Jubilant Pharmova shares?
To buy Jubilant Pharmova shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for JUBLPHARMA or Jubilant Pharmova Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Jubilant Pharmova shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Jubilant Pharmova trading volume today?
Jubilant Pharmova trading volume is 93.09K as on . This means that 93.09K shares of Jubilant Pharmova were bought and sold on the stock market during today's trading session.
What are INDmoney investors doing with Jubilant Pharmova shares right now?
Based on aggregated, anonymised INDmoney platform data, search interest and investment activity in Jubilant Pharmova have both increased over the past 30 days, and the average INDmoney investor holds the stock for 44 days. This reflects platform activity only and is not investment advice.